Clinical Trials

Showing 1166 Clinical Trials

Sort by:

Intranasal Ketamine for Procedural Sedation

Start Date: October 2022 Updated: August 2017

Ketamine

Phase 3

Unknown status
Effects of Low-dose Ketamine as an Adjunct to Propofol-based Anesthesia for Electroconvulsive Therapy

Start Date: October 2022 Updated: April 2021

Edmonton, Alberta, Canada

Ketamine

Phase 4

Completed
The Effect of Sodium Oxybate on Sleep Architecture

Start Date: October 2022 Updated: February 2018

Boston, Massachusetts, USA

GHB

Phase 2

Withdrawn
Trial of Xyrem (Sodium Oxybate) for the Treatment of Narcolepsy

Start Date: October 2022 Updated: November 2013

Toronto, Ontario, Canada

GHB

Phase 3

Completed
Pragmatic Trial of Psilocybin Therapy in Palliative Care

Start Date: October 2022 Updated: June 2022

Psilocybin

Phase 2

Not yet recruiting
Psilocybin-assisted Therapy for Treatment of Alcohol Use Disorder

Start Date: October 2022 Updated: June 2022

Psilocybin

Phase 2

Not yet recruiting
Evaluation of the Efficacy of Sodium Oxybate (Xyrem) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia

Start Date: September 2022 Updated: March 2021

Boston, Massachusetts, USA

GHB

Early Phase 1

Withdrawn
Intravenous Sub-dissociative Dose Ketamine Injection Versus Infusion for Analgesia in the Emergency Department

Start Date: September 2022 Updated: April 2020

Oakland, California, USA

Ketamine

Phase 4

Completed
Assessing the Efficacy of Micro-dosed Psilocybin on Reducing Anxiety & Depression Levels in Adults

Start Date: September 2022 Updated: February 2022

Kingston, Jamaica

Psilocybin

Phase 2

Not yet recruiting
Ketamine for Depression and Suicide Risk

Start Date: September 2022 Updated: August 2017

Rochester, Minnesota, USA

Ketamine

Phase 2

Completed

Clinical Trials

What Data is Included?